Page last updated: 2024-09-03

5-(4-acetamidophenyl)pyrazin-2(1h)-one and atenolol

5-(4-acetamidophenyl)pyrazin-2(1h)-one has been researched along with atenolol in 1 studies

Compound Research Comparison

Studies
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)
Trials
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)
Recent Studies (post-2010)
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)
Studies
(atenolol)
Trials
(atenolol)
Recent Studies (post-2010) (atenolol)
38005,4731,950852

Protein Interaction Comparison

ProteinTaxonomy5-(4-acetamidophenyl)pyrazin-2(1h)-one (IC50)atenolol (IC50)
Beta-1 adrenergic receptorHomo sapiens (human)0.7468
Alpha-1D adrenergic receptorHomo sapiens (human)0.23
Alpha-1A adrenergic receptorHomo sapiens (human)0.23
Alpha-1B adrenergic receptorHomo sapiens (human)0.23

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lugnier, C; Muller, B; Stoclet, JC1

Other Studies

1 other study(ies) available for 5-(4-acetamidophenyl)pyrazin-2(1h)-one and atenolol

ArticleYear
Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Atenolol; Calcium Chloride; Colforsin; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyrazines; Pyrrolidinones; Reserpine; Rolipram; Stereoisomerism; Xanthines

1990